Growth Strategy: AstraZeneca Launches APAC Headquarters In Shanghai
This article was originally published in PharmAsia News
Executive Summary
The second largest pharma company in China has opened a new Asia-Pacific headquarters in Shanghai’s Zhangjiang Hi-tech Park as it looks to jumpstart growth that has recently slowed.